Some of the most prominent names in biotechnology plunged on Thursday as the Nasdaq headed for its worst day in nearly two years.
Read MoreThe latest on the markets
It seems few investors are getting behind Twitter's stock as the micro-blogging company readies to report earnings Tuesday.
The "Fast Money" Final Trade.
Giving to your children while you're still living is more satisfying than leaving instructions in a will to be followed when you're no longer around.
It's about to get way worse for this lagging sector, according to a market technician at Sterne Agee.
Get the best of CNBC in your inbox